Harbour Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $186K | Sell |
354
-49
| -12% | -$25.7K | ﹤0.01% | 1205 |
|
|
2025
Q1 | $256K | Sell |
403
-32
| -7% | -$20.3K | 0.01% | 992 |
|
|
2024
Q4 | $310K | Sell |
435
-13
| -3% | -$9.26K | 0.01% | 858 |
|
|
2024
Q3 | $471K | Sell |
448
-13
| -3% | -$13.7K | 0.01% | 683 |
|
|
2024
Q2 | $485K | Sell |
461
-92
| -17% | -$96.7K | 0.02% | 610 |
|
|
2024
Q1 | $532K | Buy |
553
+162
| +41% | +$156K | 0.02% | 572 |
|
|
2023
Q4 | $343K | Buy |
391
+7
| +2% | +$6.15K | 0.01% | 669 |
|
|
2023
Q3 | $316K | Sell |
384
-72
| -16% | -$59.3K | 0.02% | 633 |
|
|
2023
Q2 | $328K | Buy |
456
+63
| +16% | +$45.3K | 0.02% | 630 |
|
|
2023
Q1 | $323K | Sell |
393
-3
| -0.8% | -$2.47K | 0.02% | 601 |
|
|
2022
Q4 | $286K | Buy |
396
+7
| +2% | +$5.05K | 0.02% | 614 |
|
|
2022
Q3 | $230K | Hold |
389
| – | – | 0.02% | 638 |
|
|
2022
Q2 | $230K | Buy |
+389
| New | +$230K | 0.02% | 638 |
|
|
2021
Q4 | $256K | Buy |
405
+46
| +13% | +$29.1K | 0.02% | 628 |
|
|
2021
Q3 | $217K | Sell |
359
-5
| -1% | -$3.02K | 0.01% | 984 |
|
|
2021
Q2 | $203K | Sell |
364
-54
| -13% | -$30.1K | 0.01% | 1036 |
|
|
2021
Q1 | $198K | Buy |
+418
| New | +$198K | 0.01% | 966 |
|